Part D Will Temper Growth In National Drug Spending In 2006, CMS Reports
This article was originally published in The Pink Sheet Daily
You may also be interested in...
Drug Safety Contributed To Overall Slowdown In 2005 U.S. Drug Spend
The agency’s annual U.S. Health Spending Projections predicts drug spending growth will fall from roughly 8% in 2005 to 7.7% in 2006.
Barr’s Expanded Thalidomide ANDA Could Increase Likelihood Of A Marketed Generic
Amended application includes 50 mg and 100 mg dosage forms, which are used in multiple myeloma.